Prestige Consumer Healthcare Inc. Quarterly Cost of Revenue in USD from Q2 2016 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Prestige Consumer Healthcare Inc. quarterly/annual Cost of Revenue history and growth rate from Q2 2016 to Q2 2024.
  • Prestige Consumer Healthcare Inc. Cost of Revenue for the quarter ending June 30, 2024 was $121M, a 2.82% decline year-over-year.
  • Prestige Consumer Healthcare Inc. Cost of Revenue for the twelve months ending June 30, 2024 was $497M, a 2.5% decline year-over-year.
  • Prestige Consumer Healthcare Inc. annual Cost of Revenue for 2023 was $501M, a 0.3% decline from 2022.
  • Prestige Consumer Healthcare Inc. annual Cost of Revenue for 2022 was $502M, a 7.78% increase from 2021.
  • Prestige Consumer Healthcare Inc. annual Cost of Revenue for 2021 was $466M, a 17.8% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $497M $121M -$3.52M -2.82% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $501M $125M -$6.93M -5.25% Jan 1, 2024 Mar 31, 2024 10-K 2024-05-15
Q4 2023 $508M $125M -$319K -0.26% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-08
Q3 2023 $508M $126M -$1.97M -1.53% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $510M $125M +$7.7M +6.58% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $502M $132M +$14M +11.9% Jan 1, 2023 Mar 31, 2023 10-K 2024-05-15
Q4 2022 $488M $125M +$5.71M +4.78% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-08
Q3 2022 $483M $128M +$9.75M +8.23% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $473M $117M +$6.77M +6.15% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $466M $118M +$17.4M +17.2% Jan 1, 2022 Mar 31, 2022 10-K 2024-05-15
Q4 2021 $449M $119M +$19.5M +19.5% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-02
Q3 2021 $429M $119M +$18.8M +18.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $411M $110M +$14.6M +15.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $396M $101M -$6.62M -6.17% Jan 1, 2021 Mar 31, 2021 10-K 2023-05-05
Q4 2020 $403M $99.9M -$4.16M -3.99% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-03
Q3 2020 $407M $99.8M -$1.56M -1.54% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $408M $95.5M -$2.56M -2.61% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $411M $107M +$4.55M +4.42% Jan 1, 2020 Mar 31, 2020 10-K 2020-05-08
Q4 2019 $406M $104M +$1.88M +1.84% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-04
Q3 2019 $404M $101M -$567K -0.56% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $405M $98.1M -$15.3M -13.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $420M $103M -$11.9M -10.4% Jan 1, 2019 Mar 31, 2019 10-K 2020-05-08
Q4 2018 $432M $102M -$20.8M -16.9% Oct 1, 2018 Dec 31, 2018 10-K 2020-05-08
Q3 2018 $453M $102M -$12M -10.6% Jul 1, 2018 Sep 30, 2018 10-K 2020-05-08
Q2 2018 $465M $113M +$260K +0.23% Apr 1, 2018 Jun 30, 2018 10-K 2020-05-08
Q1 2018 $465M $115M +$4.22M +3.82% Jan 1, 2018 Mar 31, 2018 10-K 2019-05-13
Q4 2017 $460M $123M +$30.7M +33.3% Oct 1, 2017 Dec 31, 2017 10-K 2019-05-13
Q3 2017 $430M $114M +$22.8M +25.1% Jul 1, 2017 Sep 30, 2017 10-K 2019-05-13
Q2 2017 $407M $113M +$25.1M +28.5% Apr 1, 2017 Jun 30, 2017 10-K 2019-05-13
Q1 2017 $382M $110M Jan 1, 2017 Mar 31, 2017 10-K 2018-05-10
Q4 2016 $92.2M Oct 1, 2016 Dec 31, 2016 10-K 2018-05-10
Q3 2016 $91.1M Jul 1, 2016 Sep 30, 2016 10-K 2018-05-10
Q2 2016 $88M Apr 1, 2016 Jun 30, 2016 10-K 2018-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.